NATURE . COM {}
Title:
EMBER creates a unified space for independent breast cancer transcriptomic datasets enabling precision oncology | npj Breast Cancer
Description:
Transcriptomics has revolutionized biomedical research and refined breast cancer subtyping and diagnostics. However, wider use in clinical practice is hampered for a number of reasons including the application of transcriptomic signatures as single sample predictors. Here, we present an embedding approach called EMBER that creates a unified space of 11,000 breast cancer transcriptomes and predicts phenotypes of transcriptomic profiles on a single sample basis. EMBER accurately captures the five molecular subtypes. Key biological pathways, such as estrogen receptor signaling, cell proliferation, DNA repair, and epithelial-mesenchymal transition determine sample position in the space. We validate EMBER in four independent patient cohorts and show with samples from the window trial, POETIC, that it captures clinical responses to endocrine therapy and identifies increased androgen receptor signaling and decreased TGFβ signaling as potential mechanisms underlying intrinsic therapy resistance. Of direct clinical importance, we show that the EMBER-based estrogen receptor (ER) signaling score is superior to the immunohistochemistry (IHC) based ER index used in current clinical practice to select patients for endocrine therapy. As such, EMBER provides a calibration and reference tool that paves the way for using RNA-seq as a standard diagnostic and predictive tool for ER+ breast cancer.
Website Age:
30 years and 1 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (9)
google.com, onomagic.com, onlinemediasolutions.com, sparcmedia.com, brightcom.com, audienciad.com, aps.amazon.com, yourbow.com, x.adprime.comReseller Advertisers (40)
rubiconproject.com, pubmatic.com, appnexus.com, video.unrulymedia.com, sharethrough.com, google.com, smartadserver.com, onetag.com, openx.com, yahoo.com, triplelift.com, media.net, smaato.com, conversantmedia.com, inmobi.com, themediagrid.com, indexexchange.com, 33across.com, adingo.jp, contextweb.com, axonix.com, outbrain.com, instreamatic.com, omnifytv.com, 152media.info, consumable.com, atasdigital.com, krushmedia.com, rhythmone.com, amxrtb.com, yieldmo.com, adyoulike.com, adform.com, adpone.com, criteo.com, lijit.com, richaudience.com, sovrn.com, improvedigital.com, smilewanted.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
Display Ads ~ $48,000 per month
Our calculations suggest that Nature.com earns between $32,032 and $88,088 monthly online from display advertisements.
Keywords {🔍}
samples, cancer, breast, molecular, article, metabric, fig, ember, scores, scanb, pubmed, data, signaling, genes, google, scholar, tcga, index, score, analysis, ihc, patients, average, estrogen, clinical, cohorts, embedding, sample, expression, response, cas, gene, supplementary, patient, therapy, endocrine, cohort, figure, early, nature, subtypes, receptor, information, central, space, poetic, pcpc, signatures, rnaseq, tumor,
Topics {✒️}
loading [mathjax]/jax/output/html-css/config nature portfolio code availability author information authors pi3k/akt/mtor signaling drive data availability editing molecular markers adjacent sections regional office nature 406 nature 486 nature 490 nature 462 nature leveraging patient-partnered research encompass single-sample-based approaches34 powerful tools $${\rm{cv}}=\frac{{\rm{standard pi3k/akt/mtor signaling pgc-1α-responsive genes involved figures initiative sharing original author experimental cancer research author correspondence reprints provided additional information additional biological information early-stage breast cancer io/transcriptomics epithelial-mesenchymal transition open manner35 revolutionized biomedical research cancer research npj breast cancer accession code gse105777 io/molecular_landscape including stephen-john sammut asco/cap guideline update discussion genomics data rna sequencing-based datasets similar content breast cancer index early breast cancer additional biological features large-scale multicenter infrastructure ember-based estrogen receptor
Schema {🗺️}
WebPage:
mainEntity:
headline:EMBER creates a unified space for independent breast cancer transcriptomic datasets enabling precision oncology
description:Transcriptomics has revolutionized biomedical research and refined breast cancer subtyping and diagnostics. However, wider use in clinical practice is hampered for a number of reasons including the application of transcriptomic signatures as single sample predictors. Here, we present an embedding approach called EMBER that creates a unified space of 11,000 breast cancer transcriptomes and predicts phenotypes of transcriptomic profiles on a single sample basis. EMBER accurately captures the five molecular subtypes. Key biological pathways, such as estrogen receptor signaling, cell proliferation, DNA repair, and epithelial-mesenchymal transition determine sample position in the space. We validate EMBER in four independent patient cohorts and show with samples from the window trial, POETIC, that it captures clinical responses to endocrine therapy and identifies increased androgen receptor signaling and decreased TGFβ signaling as potential mechanisms underlying intrinsic therapy resistance. Of direct clinical importance, we show that the EMBER-based estrogen receptor (ER) signaling score is superior to the immunohistochemistry (IHC) based ER index used in current clinical practice to select patients for endocrine therapy. As such, EMBER provides a calibration and reference tool that paves the way for using RNA-seq as a standard diagnostic and predictive tool for ER+ breast cancer.
datePublished:2024-07-09T00:00:00Z
dateModified:2024-07-09T00:00:00Z
pageStart:1
pageEnd:12
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1038/s41523-024-00665-z
keywords:
Breast cancer
Cancer genomics
Predictive markers
Biomedicine
general
Cancer Research
Oncology
Human Genetics
Cell Biology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig6_HTML.png
isPartOf:
name:npj Breast Cancer
issn:
2374-4677
volumeNumber:10
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Carlos Ronchi
url:http://orcid.org/0000-0002-8079-8643
affiliation:
name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
address:
name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
type:PostalAddress
type:Organization
type:Person
name:Syed Haider
url:http://orcid.org/0000-0001-6685-5480
affiliation:
name:The Institute of Cancer Research
address:
name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
type:PostalAddress
type:Organization
type:Person
name:Cathrin Brisken
url:http://orcid.org/0000-0002-6857-3230
affiliation:
name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
address:
name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
type:PostalAddress
type:Organization
name:The Institute of Cancer Research
address:
name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:EMBER creates a unified space for independent breast cancer transcriptomic datasets enabling precision oncology
description:Transcriptomics has revolutionized biomedical research and refined breast cancer subtyping and diagnostics. However, wider use in clinical practice is hampered for a number of reasons including the application of transcriptomic signatures as single sample predictors. Here, we present an embedding approach called EMBER that creates a unified space of 11,000 breast cancer transcriptomes and predicts phenotypes of transcriptomic profiles on a single sample basis. EMBER accurately captures the five molecular subtypes. Key biological pathways, such as estrogen receptor signaling, cell proliferation, DNA repair, and epithelial-mesenchymal transition determine sample position in the space. We validate EMBER in four independent patient cohorts and show with samples from the window trial, POETIC, that it captures clinical responses to endocrine therapy and identifies increased androgen receptor signaling and decreased TGFβ signaling as potential mechanisms underlying intrinsic therapy resistance. Of direct clinical importance, we show that the EMBER-based estrogen receptor (ER) signaling score is superior to the immunohistochemistry (IHC) based ER index used in current clinical practice to select patients for endocrine therapy. As such, EMBER provides a calibration and reference tool that paves the way for using RNA-seq as a standard diagnostic and predictive tool for ER+ breast cancer.
datePublished:2024-07-09T00:00:00Z
dateModified:2024-07-09T00:00:00Z
pageStart:1
pageEnd:12
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1038/s41523-024-00665-z
keywords:
Breast cancer
Cancer genomics
Predictive markers
Biomedicine
general
Cancer Research
Oncology
Human Genetics
Cell Biology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_Fig6_HTML.png
isPartOf:
name:npj Breast Cancer
issn:
2374-4677
volumeNumber:10
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Carlos Ronchi
url:http://orcid.org/0000-0002-8079-8643
affiliation:
name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
address:
name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
type:PostalAddress
type:Organization
type:Person
name:Syed Haider
url:http://orcid.org/0000-0001-6685-5480
affiliation:
name:The Institute of Cancer Research
address:
name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
type:PostalAddress
type:Organization
type:Person
name:Cathrin Brisken
url:http://orcid.org/0000-0002-6857-3230
affiliation:
name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
address:
name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
type:PostalAddress
type:Organization
name:The Institute of Cancer Research
address:
name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:npj Breast Cancer
issn:
2374-4677
volumeNumber:10
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
address:
name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
type:PostalAddress
name:The Institute of Cancer Research
address:
name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
type:PostalAddress
name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
address:
name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
type:PostalAddress
name:The Institute of Cancer Research
address:
name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Carlos Ronchi
url:http://orcid.org/0000-0002-8079-8643
affiliation:
name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
address:
name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
type:PostalAddress
type:Organization
name:Syed Haider
url:http://orcid.org/0000-0001-6685-5480
affiliation:
name:The Institute of Cancer Research
address:
name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
type:PostalAddress
type:Organization
name:Cathrin Brisken
url:http://orcid.org/0000-0002-6857-3230
affiliation:
name:Ecole Polytechnique Fédérale de Lausanne (EPFL)
address:
name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
type:PostalAddress
type:Organization
name:The Institute of Cancer Research
address:
name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
name:ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
name:The Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
Social Networks {👍}(2)
External Links {🔗}(165)
- http://orcid.org/0000-0002-8079-8643
- http://orcid.org/0000-0001-6685-5480
- http://orcid.org/0000-0002-6857-3230
- https://data.mendeley.com/datasets/yzxtxn4nmd
- https://chronchi.github.io/transcriptomics
- https://github.com/chronchi/ember
- https://github.com/chronchi/molecular_landscape
- https://chronchi.github.io/molecular_landscape
- https://doi.org/10.1023%2FA%3A1020299707510
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12408373
- http://scholar.google.com/scholar_lookup?&title=Estrogen%20receptor%20breast%20cancer%20phenotypes%20in%20the%20Surveillance%2C%20Epidemiology%2C%20and%20End%20Results%20database&journal=Breast%20Cancer%20Res%20Treat.&doi=10.1023%2FA%3A1020299707510&volume=76&pages=27-36&publication_year=2002&author=Anderson%2CWF&author=Chatterjee%2CN&author=Ershler%2CWB&author=Brawley%2COW
- https://doi.org/10.1200%2FJCO.19.02309
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31928404
- http://scholar.google.com/scholar_lookup?&title=Estrogen%20and%20Progesterone%20Receptor%20Testing%20in%20Breast%20Cancer%3A%20ASCO%2FCAP%20Guideline%20Update&journal=J.%20Clin.%20Oncol.&doi=10.1200%2FJCO.19.02309&volume=38&pages=1346-1366&publication_year=2020&author=Allison%2CKH
- https://doi.org/10.1038%2F35021093
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10963602
- http://scholar.google.com/scholar_lookup?&title=Molecular%20portraits%20of%20human%20breast%20tumours&journal=Nature&doi=10.1038%2F35021093&volume=406&pages=747-752&publication_year=2000&author=Perou%2CCM
- https://doi.org/10.1038%2Fnature10983
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22522925
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440846
- http://scholar.google.com/scholar_lookup?&title=The%20genomic%20and%20transcriptomic%20architecture%20of%202%2C000%20breast%20tumours%20reveals%20novel%20subgroups&journal=Nature&doi=10.1038%2Fnature10983&volume=486&pages=346-352&publication_year=2012&author=Curtis%2CC
- https://link.springer.com/doi/10.1186/bcr3038
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21999244
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262211
- http://scholar.google.com/scholar_lookup?&title=Prognostic%20utility%20of%20the%20breast%20cancer%20index%20and%20comparison%20to%20Adjuvant%21%20Online%20in%20a%20clinical%20case%20series%20of%20early%20breast%20cancer&journal=Breast%20Cancer%20Res.&doi=10.1186%2Fbcr3038&volume=13&publication_year=2011&author=Jankowitz%2CRC
- https://doi.org/10.1056%2FNEJMoa1602253
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27557300
- http://scholar.google.com/scholar_lookup?&title=70-Gene%20Signature%20as%20an%20Aid%20to%20Treatment%20Decisions%20in%20Early-Stage%20Breast%20Cancer&journal=N.%20Engl.%20J.%20Med&doi=10.1056%2FNEJMoa1602253&volume=375&pages=717-729&publication_year=2016&author=Cardoso%2CF
- https://doi.org/10.1158%2F1078-0432.CCR-11-0926
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21807638
- http://scholar.google.com/scholar_lookup?&title=A%20New%20Molecular%20Predictor%20of%20Distant%20Recurrence%20in%20ER-Positive%2C%20HER2-Negative%20Breast%20Cancer%20Adds%20Independent%20Information%20to%20Conventional%20Clinical%20Risk%20Factors&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-11-0926&volume=17&pages=6012-6020&publication_year=2011&author=Filipits%2CM
- https://doi.org/10.1056%2FNEJMoa1804710
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29860917
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172658
- http://scholar.google.com/scholar_lookup?&title=Adjuvant%20Chemotherapy%20Guided%20by%20a%2021-Gene%20Expression%20Assay%20in%20Breast%20Cancer&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJMoa1804710&volume=379&pages=111-121&publication_year=2018&author=Sparano%2CJA
- https://doi.org/10.1200%2FJCO.2008.18.1370
- http://scholar.google.com/scholar_lookup?&title=Supervised%20Risk%20Predictor%20of%20Breast%20Cancer%20Based%20on%20Intrinsic%20Subtypes&journal=JCO&doi=10.1200%2FJCO.2008.18.1370&volume=27&pages=1160-1167&publication_year=2009&author=Parker%2CJS
- https://doi.org/10.1200%2FJCO.20.00853
- http://scholar.google.com/scholar_lookup?&title=Molecular%20Drivers%20of%20Oncotype%20DX%2C%20Prosigna%2C%20EndoPredict%2C%20and%20the%20Breast%20Cancer%20Index%3A%20A%20TransATAC%20Study&journal=JCO&doi=10.1200%2FJCO.20.00853&volume=39&pages=126-135&publication_year=2021&author=Buus%2CR
- https://doi.org/10.15252%2Femmm.202012118
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32926574
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539222
- http://scholar.google.com/scholar_lookup?&title=The%20mutational%20landscape%20of%20the%20SCAN-B%20real-world%20primary%20breast%20cancer%20transcriptome&journal=EMBO%20Mol.%20Med.&doi=10.15252%2Femmm.202012118&volume=12&publication_year=2020&author=Brueffer%2CC
- https://doi.org/10.1093%2Fjncics%2Fpkab028
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33937624
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060794
- http://scholar.google.com/scholar_lookup?&title=Preexisting%20Somatic%20Mutations%20of%20Estrogen%20Receptor%20Alpha%20%28ESR1%29%20in%20Early-Stage%20Primary%20Breast%20Cancer&journal=JNCI%20Cancer%20Spectr.&doi=10.1093%2Fjncics%2Fpkab028&volume=5&publication_year=2021&author=Dahlgren%2CM
- https://doi.org/10.1158%2F1078-0432.CCR-19-0075
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31340938
- http://scholar.google.com/scholar_lookup?&title=Prediction%20of%20Lymph%20Node%20Metastasis%20in%20Breast%20Cancer%20by%20Gene%20Expression%20and%20Clinicopathological%20Models%3A%20Development%20and%20Validation%20within%20a%20Population-Based%20Cohort&journal=Clin.%20Cancer%20Res.&doi=10.1158%2F1078-0432.CCR-19-0075&volume=25&pages=6368-6381&publication_year=2019&author=Dihge%2CL
- https://link.springer.com/doi/10.1186/s13073-015-0131-9
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25722745
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341872
- http://scholar.google.com/scholar_lookup?&title=The%20Sweden%20Cancerome%20Analysis%20Network%20-%20Breast%20%28SCAN-B%29%20Initiative%3A%20a%20large-scale%20multicenter%20infrastructure%20towards%20implementation%20of%20breast%20cancer%20genomic%20analyses%20in%20the%20clinical%20routine&journal=Genome%20Med.&doi=10.1186%2Fs13073-015-0131-9&volume=7&publication_year=2015&author=Saal%2CLH
- https://doi.org/10.1038%2Fs41523-022-00465-3
- http://scholar.google.com/scholar_lookup?&title=RNA%20sequencing-based%20single%20sample%20predictors%20of%20molecular%20subtype%20and%20risk%20of%20recurrence%20for%20clinical%20assessment%20of%20early-stage%20breast%20cancer&journal=npj%20Breast%20Cancer&doi=10.1038%2Fs41523-022-00465-3&volume=8&pages=1-17&publication_year=2022&author=Staaf%2CJ
- https://doi.org/10.1038%2Fnature11412
- http://scholar.google.com/scholar_lookup?&title=Comprehensive%20molecular%20portraits%20of%20human%20breast%20tumours&journal=Nature&doi=10.1038%2Fnature11412&volume=490&pages=61-70&publication_year=2012&author=Koboldt%2CDC
- https://doi.org/10.1093%2Fnar%2Fgkaa802
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32997146
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641762
- http://scholar.google.com/scholar_lookup?&title=Stable%20gene%20expression%20for%20normalisation%20and%20single-sample%20scoring&journal=Nucleic%20Acids%20Res.&doi=10.1093%2Fnar%2Fgkaa802&volume=48&publication_year=2020&author=Bhuva%2CDD&author=Cursons%2CJ&author=Davis%2CMJ
- https://doi.org/10.1111%2Fhis.13089
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27648723
- http://scholar.google.com/scholar_lookup?&title=Further%20evidence%20to%20support%20bimodality%20of%20oestrogen%20receptor%20expression%20in%20breast%20cancer&journal=Histopathology&doi=10.1111%2Fhis.13089&volume=70&pages=456-465&publication_year=2017&author=Muftah%2CAA
- https://doi.org/10.1093%2Fbioinformatics%2Fbtr260
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21546393
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106198
- http://scholar.google.com/scholar_lookup?&title=Molecular%20signatures%20database%20%28MSigDB%29%203.0&journal=Bioinformatics&doi=10.1093%2Fbioinformatics%2Fbtr260&volume=27&pages=1739-1740&publication_year=2011&author=Liberzon%2CA
- https://doi.org/10.1038%2Fs41592-019-0619-0
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31740819
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884693
- http://scholar.google.com/scholar_lookup?&title=Fast%2C%20sensitive%20and%20accurate%20integration%20of%20single-cell%20data%20with%20Harmony&journal=Nat.%20Methods&doi=10.1038%2Fs41592-019-0619-0&volume=16&pages=1289-1296&publication_year=2019&author=Korsunsky%2CI
- https://doi.org/10.18632%2Foncotarget.18242
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29088770
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650325
- http://scholar.google.com/scholar_lookup?&title=Correlation%20analysis%20between%20molecular%20subtypes%20and%20Nottingham%20Prognostic%20Index%20in%20breast%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.18242&volume=8&pages=74096-74105&publication_year=2017&author=Zhen%2CH
- https://doi.org/10.17632/yzxtxn4nmd.3
- https://doi.org/10.1038%2Fs41467-018-04129-4
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29713003
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928087
- http://scholar.google.com/scholar_lookup?&title=Multi-omics%20profiling%20of%20younger%20Asian%20breast%20cancers%20reveals%20distinctive%20molecular%20signatures&journal=Nat.%20Commun.&doi=10.1038%2Fs41467-018-04129-4&volume=9&publication_year=2018&author=Kan%2CZ
- https://doi.org/10.1038%2Fs41467-022-30898-0
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35668111
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170711
- http://scholar.google.com/scholar_lookup?&title=Estrogen%20receptor%20positive%20breast%20cancers%20have%20patient%20specific%20hormone%20sensitivities%20and%20rely%20on%20progesterone%20receptor&journal=Nat.%20Commun.&doi=10.1038%2Fs41467-022-30898-0&volume=13&publication_year=2022&author=Scabia%2CV
- https://link.springer.com/doi/10.1186/s12920-019-0643-z
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31856832
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924022
- http://scholar.google.com/scholar_lookup?&title=RNA-seq%20from%20archival%20FFPE%20breast%20cancer%20samples%3A%20molecular%20pathway%20fidelity%20and%20novel%20discovery&journal=BMC%20Med.%20Genomics&doi=10.1186%2Fs12920-019-0643-z&volume=12&publication_year=2019&author=Pennock%2CND
- https://doi.org/10.1101/2023.06.07.23291117
- https://link.springer.com/doi/10.1007/s10549-012-2143-0
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22752290
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413822
- http://scholar.google.com/scholar_lookup?&title=PAM50%20assay%20and%20the%20three-gene%20model%20for%20identifying%20the%20major%20and%20clinically%20relevant%20molecular%20subtypes%20of%20breast%20cancer&journal=Breast%20Cancer%20Res%20Treat.&doi=10.1007%2Fs10549-012-2143-0&volume=135&pages=301-306&publication_year=2012&author=Prat%2CA&author=Parker%2CJS&author=Fan%2CC&author=Perou%2CCM
- https://doi.org/10.1093%2Fjncimonographs%2Flgr034
- http://scholar.google.com/scholar_lookup?&title=Endocrine%20Therapy%2C%20New%20Biologicals%2C%20and%20New%20Study%20Designs%20for%20Presurgical%20Studies%20in%20Breast%20Cancer&journal=JNCI%20Monogr.&doi=10.1093%2Fjncimonographs%2Flgr034&volume=2011&pages=120-123&publication_year=2011&author=Dowsett%2CM
- https://link.springer.com/doi/10.1186/s12859-018-2435-4
- http://scholar.google.com/scholar_lookup?&title=Single%20sample%20scoring%20of%20molecular%20phenotypes&journal=BMC%20Bioinforma.&doi=10.1186%2Fs12859-018-2435-4&volume=19&publication_year=2018&author=Foroutan%2CM
- https://doi.org/10.1038%2Fnature08460
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19847166
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783335
- http://scholar.google.com/scholar_lookup?&title=Systematic%20RNA%20interference%20reveals%20that%20oncogenic%20KRAS-driven%20cancers%20require%20TBK1&journal=Nature&doi=10.1038%2Fnature08460&volume=462&pages=108-112&publication_year=2009&author=Barbie%2CDA
- https://doi.org/10.1038%2Fs41523-019-0111-0
- http://scholar.google.com/scholar_lookup?&title=SETER%2FPR%3A%20a%20robust%2018-gene%20predictor%20for%20sensitivity%20to%20endocrine%20therapy%20for%20metastatic%20breast%20cancer&journal=npj%20Breast%20Cancer&doi=10.1038%2Fs41523-019-0111-0&volume=5&pages=1-8&publication_year=2019&author=Sinn%2CBV
- https://link.springer.com/doi/10.1186/s12859-017-1925-0
- http://scholar.google.com/scholar_lookup?&title=Integration%20of%20RNA-Seq%20data%20with%20heterogeneous%20microarray%20data%20for%20breast%20cancer%20profiling&journal=BMC%20Bioinforma.&doi=10.1186%2Fs12859-017-1925-0&volume=18&publication_year=2017&author=Castillo%2CD
- https://doi.org/10.1093%2Fnar%2Fgkab554
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=34214174
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464058
- http://scholar.google.com/scholar_lookup?&title=Rank-in%3A%20enabling%20integrative%20analysis%20across%20microarray%20and%20RNA-seq%20for%20cancer&journal=Nucleic%20Acids%20Res.&doi=10.1093%2Fnar%2Fgkab554&volume=49&publication_year=2021&author=Tang%2CK
- https://doi.org/10.1016%2FS1470-2045%2810%2970008-5
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20181526
- http://scholar.google.com/scholar_lookup?&title=Breast%20cancer%20molecular%20profiling%20with%20single%20sample%20predictors%3A%20a%20retrospective%20analysis&journal=Lancet%20Oncol.&doi=10.1016%2FS1470-2045%2810%2970008-5&volume=11&pages=339-349&publication_year=2010&author=Weigelt%2CB
- https://doi.org/10.1038%2Fs41467-022-32523-6
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36008376
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411634
- http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20plasticity%20determines%20estrogen%20receptor%20positive%20breast%20cancer%20dormancy%20and%20epithelial%20reconversion%20drives%20recurrence&journal=Nat.%20Commun.&doi=10.1038%2Fs41467-022-32523-6&volume=13&publication_year=2022&author=Aouad%2CP
- https://doi.org/10.1200%2FJCO.2023.41.17_suppl.LBA500
- http://scholar.google.com/scholar_lookup?&title=Ribociclib%20and%20endocrine%20therapy%20as%20adjuvant%20treatment%20in%20patients%20with%20HR%2B%2FHER2-%20early%20breast%20cancer%3A%20Primary%20results%20from%20the%20phase%20III%20NATALEE%20trial&journal=JCO&doi=10.1200%2FJCO.2023.41.17_suppl.LBA500&volume=41&pages=LBA500-LBA500&publication_year=2023&author=Slamon%2CDJ
- https://doi.org/10.1056%2FNEJMoa2214131
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=37256976
- http://scholar.google.com/scholar_lookup?&title=Capivasertib%20in%20Hormone%20Receptor%E2%80%93Positive%20Advanced%20Breast%20Cancer&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJMoa2214131&volume=388&pages=2058-2070&publication_year=2023&author=Turner%2CNC
- https://link.springer.com/doi/10.1186/s13058-019-1223-z
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31892336
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938628
- http://scholar.google.com/scholar_lookup?&title=Impact%20of%20aromatase%20inhibitor%20treatment%20on%20global%20gene%20expression%20and%20its%20association%20with%20antiproliferative%20response%20in%20ER%2B%20breast%20cancer%20in%20postmenopausal%20patients&journal=Breast%20Cancer%20Res.&doi=10.1186%2Fs13058-019-1223-z&volume=22&publication_year=2019&author=Gao%2CQ
- https://doi.org/10.1038%2Fs41591-020-01168-7
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33462444
- http://scholar.google.com/scholar_lookup?&title=The%20androgen%20receptor%20is%20a%20tumor%20suppressor%20in%20estrogen%20receptor%E2%80%93positive%20breast%20cancer&journal=Nat.%20Med&doi=10.1038%2Fs41591-020-01168-7&volume=27&pages=310-320&publication_year=2021&author=Hickey%2CTE
- https://link.springer.com/doi/10.1007/s10549-009-0436-8
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19533338
- http://scholar.google.com/scholar_lookup?&title=Androgen%20receptor%20overexpression%20induces%20tamoxifen%20resistance%20in%20human%20breast%20cancer%20cells&journal=Breast%20Cancer%20Res%20Treat.&doi=10.1007%2Fs10549-009-0436-8&volume=121&pages=1-11&publication_year=2010&author=Amicis%2CF
- https://link.springer.com/doi/10.1186/s13058-022-01556-6
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36096872
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466340
- http://scholar.google.com/scholar_lookup?&title=Relationship%20between%20ER%20expression%20by%20IHC%20or%20mRNA%20with%20Ki67%20response%20to%20aromatase%20inhibition%3A%20a%20POETIC%20study&journal=Breast%20Cancer%20Res.&doi=10.1186%2Fs13058-022-01556-6&volume=24&publication_year=2022&author=Lopez-Knowles%2CE
- https://doi.org/10.1093%2Fbioinformatics%2Fbtm254
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17496320
- http://scholar.google.com/scholar_lookup?&title=GEOquery%3A%20a%20bridge%20between%20the%20Gene%20Expression%20Omnibus%20%28GEO%29%20and%20BioConductor&journal=Bioinformatics&doi=10.1093%2Fbioinformatics%2Fbtm254&volume=23&pages=1846-1847&publication_year=2007&author=Davis%2CS&author=Meltzer%2CPS
- https://doi.org/10.1093%2Fbioinformatics%2Fbtp616
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19910308
- http://scholar.google.com/scholar_lookup?&title=edgeR%3A%20a%20Bioconductor%20package%20for%20differential%20expression%20analysis%20of%20digital%20gene%20expression%20data&journal=Bioinformatics&doi=10.1093%2Fbioinformatics%2Fbtp616&volume=26&pages=139-140&publication_year=2010&author=Robinson%2CMD&author=McCarthy%2CDJ&author=Smyth%2CGK
- https://link.springer.com/doi/10.1186/1471-2105-14-7
- http://scholar.google.com/scholar_lookup?&title=GSVA%3A%20gene%20set%20variation%20analysis%20for%20microarray%20and%20RNA-Seq%20data&journal=BMC%20Bioinforma.&doi=10.1186%2F1471-2105-14-7&volume=14&publication_year=2013&author=H%C3%A4nzelmann%2CS&author=Castelo%2CR&author=Guinney%2CJ
- https://doi.org/10.1038%2Fng1180
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12808457
- http://scholar.google.com/scholar_lookup?&title=PGC-1%CE%B1-responsive%20genes%20involved%20in%20oxidative%20phosphorylation%20are%20coordinately%20downregulated%20in%20human%20diabetes&journal=Nat.%20Genet&doi=10.1038%2Fng1180&volume=34&pages=267-273&publication_year=2003&author=Mootha%2CVK
- https://doi.org/10.5281/zenodo.1308151
- https://citation-needed.springer.com/v2/references/10.1038/s41523-024-00665-z?format=refman&flavour=references
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Carlos%20Ronchi
- http://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Carlos%20Ronchi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Syed%20Haider
- http://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Syed%20Haider%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cathrin%20Brisken
- http://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cathrin%20Brisken%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- https://static-content.springer.com/esm/art%3A10.1038%2Fs41523-024-00665-z/MediaObjects/41523_2024_665_MOESM1_ESM.pdf
- http://creativecommons.org/licenses/by/4.0/
- https://s100.copyright.com/AppDispatchServlet?title=EMBER%20creates%20a%20unified%20space%20for%20independent%20breast%20cancer%20transcriptomic%20datasets%20enabling%20precision%20oncology&author=Carlos%20Ronchi%20et%20al&contentID=10.1038%2Fs41523-024-00665-z©right=The%20Author%28s%29&publication=2374-4677&publicationDate=2024-07-09&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY
- https://crossmark.crossref.org/dialog/?doi=10.1038/s41523-024-00665-z
- https://citation-needed.springer.com/v2/references/10.1038/s41523-024-00665-z?format=refman&flavour=citation
- https://www.protocols.io/
- https://www.natureindex.com/
- http://www.naturechina.com
- https://www.natureasia.com/ja-jp
Analytics and Tracking {📊}
- Google Analytics
- Google Tag Manager
Libraries {📚}
- Ember.js
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk